• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of stroke prevention in Bulgarian patients with non-valvular atrial fibrillation (BUL-AF Survey).

作者信息

Runev Nikolay Margaritov, Dimitrov Stamen Mitev

机构信息

Clinic of Cardiology, Department of Internal Diseases "Kirkovich", University Alexandrovska Hospital, Sofia, Bulgaria.

Medical Department, Boehringer Ingelheim RCV GmbH and Co KG, Bulgarian Branch, Bulgaria.

出版信息

Int J Cardiol. 2015;187:683-5. doi: 10.1016/j.ijcard.2015.03.420. Epub 2015 Mar 31.

DOI:10.1016/j.ijcard.2015.03.420
PMID:25910470
Abstract
摘要

相似文献

1
Management of stroke prevention in Bulgarian patients with non-valvular atrial fibrillation (BUL-AF Survey).保加利亚非瓣膜性心房颤动患者的卒中预防管理（BUL-AF调查）
Int J Cardiol. 2015;187:683-5. doi: 10.1016/j.ijcard.2015.03.420. Epub 2015 Mar 31.
2
How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.在欧洲，如何让房颤患者了解自身的风险状况及可用治疗方法？欧洲心律协会调查结果。
Europace. 2015 Mar;17(3):468-72. doi: 10.1093/europace/euv025.
3
Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).用于接受消融治疗的心房颤动患者预防卒中的口服抗凝治疗：来自首届欧洲心房颤动消融手术流程快照调查（ESS-PRAFA）的结果
Europace. 2015 Jun;17(6):986-93. doi: 10.1093/europace/euv132.
4
Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.老年非瓣膜性心房颤动患者的抗栓治疗：一项试点研究。
Clin Interv Aging. 2015 Mar 2;10:515-9. doi: 10.2147/CIA.S67974. eCollection 2015.
5
Clinically important atrial arrhythmia and stroke risk: a UK-wide online survey among stroke physicians and cardiologists.临床重要的心房性心律失常和卒中风险：英国范围内卒中医生和心脏病学家的在线调查。
QJM. 2014 Nov;107(11):895-902. doi: 10.1093/qjmed/hcu177. Epub 2014 Aug 29.
6
The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey.瓣膜性与非瓣膜性心房颤动的定义：一项医师调查结果
Europace. 2014 Dec;16(12):1720-5. doi: 10.1093/europace/euu178. Epub 2014 Aug 2.
7
Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.新型口服抗凝剂在预防心房颤动中的作用：欧洲心律协会调查结果。
Europace. 2013 Oct;15(10):1526-32. doi: 10.1093/europace/eut292.
8
Cost-effectiveness of dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain.达比加群酯用于西班牙非瓣膜性心房颤动患者卒中预防的成本效益分析
Rev Esp Cardiol (Engl Ed). 2012 Oct;65(10):901-10. doi: 10.1016/j.recesp.2012.06.006. Epub 2012 Sep 6.
9
[Chinese practical guide of dabigatran etexilate for stroke prevention in patients with non-valvular atrial fibrillation].[达比加群酯用于非瓣膜性心房颤动患者预防卒中的中国实用指南]
Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Mar;42(3):188-92.
10
Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.欧洲不同临床情况下心房颤动患者口服抗凝治疗的偏好：欧洲心律协会调查结果
Europace. 2015 May;17(5):819-24. doi: 10.1093/europace/euv116.

引用本文的文献

1
Physicians' Perceptions of Their Patients' Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria.保加利亚医生对患者长期口服抗凝治疗的态度和知识的看法。
Medicina (Kaunas). 2019 Jun 26;55(7):313. doi: 10.3390/medicina55070313.
2
Risk Factors, Co-Morbidities and Treatment of In-Hospital Patients with Atrial Fibrillation in Bulgaria.保加利亚住院心房颤动患者的风险因素、合并症和治疗。
Medicina (Kaunas). 2018 May 25;54(3):34. doi: 10.3390/medicina54030034.